Document Detail


Serum soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha levels in children with celiac disease: response to treatment.
MedLine Citation:
PMID:  12394376     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: T-cell mediated immune response to dietary gluten and cytokines release are important for the enteropathy seen in celiac disease. We investigated the serum levels of soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha in celiac children before and after gluten exclusion. METHODS: Cytokine levels were determined using enzyme immunoassay in serum from 12 untreated celiac patients, 16 treated celiac patients on a gluten-free diet for at least two years, and from 26 control children. Eight of 12 untreated patients were also investigated at 6 and 12 months after gluten exclusion. Serum IgA antiendomysium antibodies were also assayed by indirect immunofluorescence. RESULTS: Soluble interleukin-2 receptor and interleukin-6 levels were significantly increased in untreated celiac patients compared with treated and control children. There was no difference in the tumor necrosis factor-alpha levels between the groups. Soluble interleukin-2 receptor levels were the only ones significantly decreased at 12 months after gluten exclusion. However, soluble interleukin-2 receptor and interleukin-6 levels at 12 months were significantly higher compared with controls. Antiendomysium antibodies had a diagnostic sensitivity of 100% and the titers decreased significantly after 12 months of gluten exclusion. A significant positive correlation was found between antiendomysium antibody titers with both soluble interleukin-2 receptor and interleukin-6 values. CONCLUSIONS: The serum soluble interleukin-2 receptor and interleukin-6 levels may be used as a noninvasive measure of celiac disease activity and response to treatment.
Authors:
Ceres C Romaldini; Dorina Barbieri; Thelma S Okay; Roberto Raiz; Eduardo L R Cançado
Related Documents :
8777726 - Herpesvirus saimiri encodes a new cytokine, il-17, which binds to a novel cytokine rece...
11246166 - Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosi...
22630566 - Recent patenting activities in the discovery and development of vasopressin v2 receptor...
10881176 - Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin.
12486206 - Mechanism of action of progesterone antagonists.
10945226 - The major histocompatibility complex-encoded hfe in iron homeostasis and immune function.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of pediatric gastroenterology and nutrition     Volume:  35     ISSN:  0277-2116     ISO Abbreviation:  J. Pediatr. Gastroenterol. Nutr.     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-10-23     Completed Date:  2003-03-04     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8211545     Medline TA:  J Pediatr Gastroenterol Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  513-7     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Faculty of Medicine, University of São Paulo, Brazil. jhroma@netpoint.com.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Autoantibodies / blood
Celiac Disease / blood*,  diagnosis,  diet therapy,  immunology
Child
Child, Preschool
Enzyme-Linked Immunosorbent Assay
Female
Fluorescent Antibody Technique, Indirect
Gliadin / immunology
Glutens / administration & dosage,  immunology*
Humans
Immunity, Cellular
Immunoglobulin A / blood
Infant
Interleukin-6 / blood*
Male
Receptors, Interleukin-2 / blood*
Tumor Necrosis Factor-alpha / analysis*,  metabolism
Chemical
Reg. No./Substance:
0/Autoantibodies; 0/Immunoglobulin A; 0/Interleukin-6; 0/Receptors, Interleukin-2; 0/Tumor Necrosis Factor-alpha; 8002-80-0/Glutens; 9007-90-3/Gliadin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Celiac disease in India: are they true cases of celiac disease?
Next Document:  Patient web-resource interest and internet readiness in pediatric inflammatory bowel disease.